Christian Morabito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Morabito has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Mathieu Almeida
Université Paris-Saclay, INRAE, MetaGenoPolis (MGP), Jouy-en-Josas, France
8 shared publications - Benoit Quinquis
Université Paris-Saclay, INRAE, MGP, Jouy-en-Josas, France
7 shared publications - Stanislav Dusko Ehrlich
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK
7 shared publications - Eric Maréchal
Laboratoire de Physiologie Cellulaire et Végétale, Université Grenoble-Alpes CEA CNRS INRAE IRIG-CEA Grenoble, 17 rue des Martyrs, Grenoble Cedex 9, 38054, France.
6 shared publications - Alberto Amato
Laboratoire de Physiologie Cellulaire et Végétale, Université Grenoble-Alpes CEA CNRS INRAE IRIG-CEA Grenoble, 17 rue des Martyrs, Grenoble Cedex 9, 38054, France.
5 shared publications - Hervé Modeste Blottière
INRAE, UMR 1280, PhAN, Nantes Université, F-44000 Nantes, France
5 shared publications
Latest Publications
- Open Access
Gut microbiome stratification reveals functional metabolic signatures linked to host health
The human gut microbiome exhibits reproducible taxonomic configurations, yet the ecological processes linking them to health remain unclear. We applied the five-enterosignature (ES) model to 5,169 metagenomes of Le French Gut participants and developed a rule-based framework that stratifies continuous microbiome variation into interpretable partitions. Across these partitions, hydrogen disposal pathways formed distinct functional gradients, reproduced in an international meta-cohort (n = 5,107). Partitions dominated by Prevotella enterosignature showed greater sulfate-reduction potential, ES-Firmicutes -associated partitions greater methanogenesis potential, and ES-Bacteroides -enriched partitions greater acetogenesis potential. The latter were also characterized by oxidative-stress and mucin-degradation signatures, altered fecal mucin O-glycosylation, and less favorable health indicators, including more frequent digestive symptoms, higher perceived stress, and more psychotropic drug prescriptions. These patterns were also accompanied by distinct dietary profiles. Our findings link hydrogen metabolism, redox-associated functions, mucin utilization, diet, and host health, and support enterosignature-based partitioning for cross-cohort comparisons and future stratified interventions.
Open AccessGut microbiome stratification reveals functional metabolic signatures linked to host health
The human gut microbiome exhibits reproducible taxonomic configurations, yet the ecological processes linking them to health remain unclear. We applied the five-enterosignature (ES) model to 5,169 metagenomes of Le French Gut participants and developed a rule-based framework that stratifies continuous microbiome variation into interpretable partitions. Across these partitions, hydrogen disposal pathways formed distinct functional gradients, reproduced in an international meta-cohort (n = 5,107). Partitions dominated by Prevotella enterosignature showed greater sulfate-reduction potential, ES-Firmicutes -associated partitions greater methanogenesis potential, and ES-Bacteroides -enriched partitions greater acetogenesis potential. The latter were also characterized by oxidative-stress and mucin-degradation signatures, altered fecal mucin O-glycosylation, and less favorable health indicators, including more frequent digestive symptoms, higher perceived stress, and more psychotropic drug prescriptions. These patterns were also accompanied by distinct dietary profiles. Our findings link hydrogen metabolism, redox-associated functions, mucin utilization, diet, and host health, and support enterosignature-based partitioning for cross-cohort comparisons and future stratified interventions.
- Top Cited PapersOpen Access
- 20 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (6) , 2096-2106
Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals
Parkinson’s disease (PD) is a major cause of disability. GBA1 variants are the most common genetic risk factor for PD and increase the risk up to 30-fold. Why only approximately 20% of GBA1 variant carriers develop PD remains unknown. Here, by combining clinical and fecal metagenomics data from 271 patients with PD, from 43 carriers of GBA1 variants not manifesting PD symptoms (GBA-NMC) and from 150 healthy controls, and using an innovative microbiome analysis, combining differential abundance of species and coherence of differential abundance variation between the groups as assessed by Cliff’s delta ( δ ), we show that the composition of a large component of the gut microbiome (approximately 25%) in GBA-NMC is intermediate between healthy controls and patients with PD. This component is strongly correlated with disease progression in patients and prodromal symptoms suggestive of future development of PD in both GBA-NMC and healthy individuals. We found microbiome alterations similar to those described here in three independent cohorts from the United States, Korea and Turkey, totaling 638 patients with PD and 319 healthy controls, and we conclude that gut microbiome alterations can identify both genetically and non-genetically at-risk individuals in the general population who may be progressing toward PD, thus serving as an early marker of disease development in the premanifest phase.
- 20 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (6) , 2096-2106
Top Cited PapersOpen AccessMicrobiome signature of Parkinson’s disease in healthy and genetically at-risk individuals
Parkinson’s disease (PD) is a major cause of disability. GBA1 variants are the most common genetic risk factor for PD and increase the risk up to 30-fold. Why only approximately 20% of GBA1 variant carriers develop PD remains unknown. Here, by combining clinical and fecal metagenomics data from 271 patients with PD, from 43 carriers of GBA1 variants not manifesting PD symptoms (GBA-NMC) and from 150 healthy controls, and using an innovative microbiome analysis, combining differential abundance of species and coherence of differential abundance variation between the groups as assessed by Cliff’s delta ( δ ), we show that the composition of a large component of the gut microbiome (approximately 25%) in GBA-NMC is intermediate between healthy controls and patients with PD. This component is strongly correlated with disease progression in patients and prodromal symptoms suggestive of future development of PD in both GBA-NMC and healthy individuals. We found microbiome alterations similar to those described here in three independent cohorts from the United States, Korea and Turkey, totaling 638 patients with PD and 319 healthy controls, and we conclude that gut microbiome alterations can identify both genetically and non-genetically at-risk individuals in the general population who may be progressing toward PD, thus serving as an early marker of disease development in the premanifest phase.
- Open Access
- 14 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e80127
Correction: Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study
[This corrects the article DOI: 10.2196/64894.].
- 14 July 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e80127
Open AccessCorrection: Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study
[This corrects the article DOI: 10.2196/64894.].
- Open Access
- 4 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Correction: Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- 4 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCorrection: Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- Open Access
Microbiome signature of Parkinson disease in healthy and genetically at-risk individuals
Summary: Parkinson disease (PD) is a major cause of disability with significant personal and system financial implications 1,2 . GBA1 variants are the commonest genetic risk factor for PD and increase the risk up to 30-fold 3,4 . Why only ∼20% of GBA1 variant carriers develop PD remains unknown. Here, by combining clinical and faecal metagenomics data from PD individuals carrying or not GBA1 variants, carriers of GBA1 variants not manifesting PD symptoms (GBA-NMC) and healthy controls, and using an innovative microbiome analysis, we show that a large component of the gut microbiome evolves from healthy across GBA-NMC towards PD and is strongly correlated with disease progression in patients, and prodromal symptoms suggestive of future development of PD in GBA-NMC. By using species altered in PD and GBA-NMC, we detect healthy individuals with the strongest prodromal PD clinical profile. These findings indicate that gut microbiome alterations can identify individuals with GBA1 variants most prone to develop PD and individuals in the general population that may be progressing towards PD. Healthy nutrition mitigates microbiome alterations associated with disease severity, suggesting that it could modify disease progression in PD patients and decrease the risk of disease development in healthy individuals including those with GBA1 variants.
Open AccessMicrobiome signature of Parkinson disease in healthy and genetically at-risk individuals
Summary: Parkinson disease (PD) is a major cause of disability with significant personal and system financial implications 1,2 . GBA1 variants are the commonest genetic risk factor for PD and increase the risk up to 30-fold 3,4 . Why only ∼20% of GBA1 variant carriers develop PD remains unknown. Here, by combining clinical and faecal metagenomics data from PD individuals carrying or not GBA1 variants, carriers of GBA1 variants not manifesting PD symptoms (GBA-NMC) and healthy controls, and using an innovative microbiome analysis, we show that a large component of the gut microbiome evolves from healthy across GBA-NMC towards PD and is strongly correlated with disease progression in patients, and prodromal symptoms suggestive of future development of PD in GBA-NMC. By using species altered in PD and GBA-NMC, we detect healthy individuals with the strongest prodromal PD clinical profile. These findings indicate that gut microbiome alterations can identify individuals with GBA1 variants most prone to develop PD and individuals in the general population that may be progressing towards PD. Healthy nutrition mitigates microbiome alterations associated with disease severity, suggesting that it could modify disease progression in PD patients and decrease the risk of disease development in healthy individuals including those with GBA1 variants.
- Open Access
- 13 May 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e64894
Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study
Background: Over the past 2 decades, the gut microbiota has emerged as a key player in human health, being involved in many different clinical contexts. Yet, many aspects of the relationship with its host are poorly documented. One obstacle is the substantial variability in wet-laboratory procedures and data processing implemented during gut microbiota studies, which poses a challenge of comparability and potential meta-analysis. Objective: The study protocol described here aimed to better understand the relationship between health, dietary habits, and the observed heterogeneity of gut microbiota composition in the general population. “Le French Gut – Le microbiote français” aimed to collect, sequence, and analyze 100,000 fecal samples from French residents using a high-quality shotgun metagenomic pipeline, complemented with comprehensive health, lifestyle, and dietary metadata. Methods: “Le French Gut – Le microbiote français” is a prospective, noninterventional French national study involving individuals, the creation of a biological collection (feces), and the exploitation of data from questionnaires and the National Health Data System (Système National des Données de Santé). This national study is open to all metropolitan French adult residents, excluding those who have undergone a colectomy or digestive stoma, or who have had a colonoscopy or taken antibiotics in the last 3 months. This is a home-based trial in which volunteers complete a questionnaire with insights about their health and habits, and in which stool samples are self-collected. Data analysis is structured into 6 work packages, each focusing on a specific aspect of the gut microbiome, including its composition and associations with lifestyle, quality of life, and health. Results: This paper outlines the study protocol, with recruitment having started in September 2022 and expected to continue until the end of December 2025. As of January 2025, a total of 20,000 participants have been enrolled. The first scientific publications based on the data analysis are expected by mid-2025. Conclusions: “Le French Gut” aims to provide a reference database and new ecosystem tools for understanding the relationship between the gut microbiota, its host, and diet. We expect to be able to find new signatures or targets and promote the design of innovative preventive strategies, personalized nutrition, and precision medicine. Trial Registration: ClinicalTrials.gov NCT05758961; https://clinicaltrials.gov/study/NCT05758961 International Registered Report Identifier (IRRID): DERR1-10.2196/64894
- 13 May 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e64894
Open AccessAssociations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study
Background: Over the past 2 decades, the gut microbiota has emerged as a key player in human health, being involved in many different clinical contexts. Yet, many aspects of the relationship with its host are poorly documented. One obstacle is the substantial variability in wet-laboratory procedures and data processing implemented during gut microbiota studies, which poses a challenge of comparability and potential meta-analysis. Objective: The study protocol described here aimed to better understand the relationship between health, dietary habits, and the observed heterogeneity of gut microbiota composition in the general population. “Le French Gut – Le microbiote français” aimed to collect, sequence, and analyze 100,000 fecal samples from French residents using a high-quality shotgun metagenomic pipeline, complemented with comprehensive health, lifestyle, and dietary metadata. Methods: “Le French Gut – Le microbiote français” is a prospective, noninterventional French national study involving individuals, the creation of a biological collection (feces), and the exploitation of data from questionnaires and the National Health Data System (Système National des Données de Santé). This national study is open to all metropolitan French adult residents, excluding those who have undergone a colectomy or digestive stoma, or who have had a colonoscopy or taken antibiotics in the last 3 months. This is a home-based trial in which volunteers complete a questionnaire with insights about their health and habits, and in which stool samples are self-collected. Data analysis is structured into 6 work packages, each focusing on a specific aspect of the gut microbiome, including its composition and associations with lifestyle, quality of life, and health. Results: This paper outlines the study protocol, with recruitment having started in September 2022 and expected to continue until the end of December 2025. As of January 2025, a total of 20,000 participants have been enrolled. The first scientific publications based on the data analysis are expected by mid-2025. Conclusions: “Le French Gut” aims to provide a reference database and new ecosystem tools for understanding the relationship between the gut microbiota, its host, and diet. We expect to be able to find new signatures or targets and promote the design of innovative preventive strategies, personalized nutrition, and precision medicine. Trial Registration: ClinicalTrials.gov NCT05758961; https://clinicaltrials.gov/study/NCT05758961 International Registered Report Identifier (IRRID): DERR1-10.2196/64894
- Open Access
- 30 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Associations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study (Preprint)
BACKGROUND Over the past 2 decades, the gut microbiota has emerged as a key player in human health, being involved in many different clinical contexts. Yet, many aspects of the relationship with its host are poorly documented. One obstacle is the substantial variability in wet-laboratory procedures and data processing implemented during gut microbiota studies, which poses a challenge of comparability and potential meta-analysis. OBJECTIVE The study protocol described here aimed to better understand the relationship between health, dietary habits, and the observed heterogeneity of gut microbiota composition in the general population. “Le French Gut – Le microbiote français” aimed to collect, sequence, and analyze 100,000 fecal samples from French residents using a high-quality shotgun metagenomic pipeline, complemented with comprehensive health, lifestyle, and dietary metadata. METHODS “Le French Gut – Le microbiote français” is a prospective, noninterventional French national study involving individuals, the creation of a biological collection (feces), and the exploitation of data from questionnaires and the National Health Data System (Système National des Données de Santé). This national study is open to all metropolitan French adult residents, excluding those who have undergone a colectomy or digestive stoma, or who have had a colonoscopy or taken antibiotics in the last 3 months. This is a home-based trial in which volunteers complete a questionnaire with insights about their health and habits, and in which stool samples are self-collected. Data analysis is structured into 6 work packages, each focusing on a specific aspect of the gut microbiome, including its composition and associations with lifestyle, quality of life, and health. RESULTS This paper outlines the study protocol, with recruitment having started in September 2022 and expected to continue until the end of December 2025. As of January 2025, a total of 20,000 participants have been enrolled. The first scientific publications based on the data analysis are expected by mid-2025. CONCLUSIONS “Le French Gut” aims to provide a reference database and new ecosystem tools for understanding the relationship between the gut microbiota, its host, and diet. We expect to be able to find new signatures or targets and promote the design of innovative preventive strategies, personalized nutrition, and precision medicine. CLINICALTRIAL ClinicalTrials.gov NCT05758961; https://clinicaltrials.gov/study/NCT05758961 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/64894
- 30 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAssociations Among Diet, Health, Lifestyle, and Gut Microbiota Composition in the General French Population: Protocol for the Le French Gut – Le Microbiote Français Study (Preprint)
BACKGROUND Over the past 2 decades, the gut microbiota has emerged as a key player in human health, being involved in many different clinical contexts. Yet, many aspects of the relationship with its host are poorly documented. One obstacle is the substantial variability in wet-laboratory procedures and data processing implemented during gut microbiota studies, which poses a challenge of comparability and potential meta-analysis. OBJECTIVE The study protocol described here aimed to better understand the relationship between health, dietary habits, and the observed heterogeneity of gut microbiota composition in the general population. “Le French Gut – Le microbiote français” aimed to collect, sequence, and analyze 100,000 fecal samples from French residents using a high-quality shotgun metagenomic pipeline, complemented with comprehensive health, lifestyle, and dietary metadata. METHODS “Le French Gut – Le microbiote français” is a prospective, noninterventional French national study involving individuals, the creation of a biological collection (feces), and the exploitation of data from questionnaires and the National Health Data System (Système National des Données de Santé). This national study is open to all metropolitan French adult residents, excluding those who have undergone a colectomy or digestive stoma, or who have had a colonoscopy or taken antibiotics in the last 3 months. This is a home-based trial in which volunteers complete a questionnaire with insights about their health and habits, and in which stool samples are self-collected. Data analysis is structured into 6 work packages, each focusing on a specific aspect of the gut microbiome, including its composition and associations with lifestyle, quality of life, and health. RESULTS This paper outlines the study protocol, with recruitment having started in September 2022 and expected to continue until the end of December 2025. As of January 2025, a total of 20,000 participants have been enrolled. The first scientific publications based on the data analysis are expected by mid-2025. CONCLUSIONS “Le French Gut” aims to provide a reference database and new ecosystem tools for understanding the relationship between the gut microbiota, its host, and diet. We expect to be able to find new signatures or targets and promote the design of innovative preventive strategies, personalized nutrition, and precision medicine. CLINICALTRIAL ClinicalTrials.gov NCT05758961; https://clinicaltrials.gov/study/NCT05758961 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/64894
- Open Access
- 8 February 2024
- Published by Springer Nature
Protocol for DNA extraction and shotgun metagenomic sequencing for the study of the mice digestive microbiota v1
This protocol describes the procedures for whole DNA extraction, high throughput sequencing, metagenomic read mapping and bioinformatical pre-processing to determine the microbial composition and functional potential of the mice digestive microbiota.
- 8 February 2024
- Published by Springer Nature
Open AccessProtocol for DNA extraction and shotgun metagenomic sequencing for the study of the mice digestive microbiota v1
This protocol describes the procedures for whole DNA extraction, high throughput sequencing, metagenomic read mapping and bioinformatical pre-processing to determine the microbial composition and functional potential of the mice digestive microbiota.
- Open Access
- 8 February 2024
- Published by Springer Nature
DNA extraction protocol for saliva samples obtained from Omigene oral OM device using the Qiagen QiaAMP Powerfecal DNA kit for shotgun metagenomic sequencing v1
This protocol describes the procedure for DNA extraction of saliva samples using the Omnigene OM device and the Qiagen QiaMP Powerfecal DNA PRO kit for shotgun metagenomic sequencing.
- 8 February 2024
- Published by Springer Nature
Open AccessDNA extraction protocol for saliva samples obtained from Omigene oral OM device using the Qiagen QiaAMP Powerfecal DNA kit for shotgun metagenomic sequencing v1
This protocol describes the procedure for DNA extraction of saliva samples using the Omnigene OM device and the Qiagen QiaMP Powerfecal DNA PRO kit for shotgun metagenomic sequencing.
- Open Access
- 23 August 2023
- Published by Springer Nature in Research Square
Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics
The importance of oral microbiota has been recently highlighted in human health, such as in Parkinson disease, notably using shotgun metagenomics. One key aspect for efficient shotgun metagenomic analysis relies on optimal microbial sampling and DNA extraction, generally implementing commercial solutions developed to improve sample collection and preservation and provide high DNA quality and quantity for downstream analysis. Because metagenomic studies are today performed on a large number of samples, the next evolution to increase study throughput is with DNA extraction automation. In this study, we proposed a semi-automated DNA extraction protocol for human salivary samples collected with a commercial kit, and compared the outcomes with the DNA extraction recommended by the manufacturer. While similar DNA yields were observed between the protocols, our semi-automated DNA protocol significantly generated higher DNA fragment sizes. Moreover, we showed that the oral microbiome composition was equivalent between DNA extraction methods, even at the species level. This study demonstrates that our semi-automated protocol is suitable for shotgun metagenomic analysis, while allowing for a better sample treatment logistic with reduced technical variability and without compromising the structure of the oral microbiome.
- 23 August 2023
- Published by Springer Nature in Research Square
Open AccessEvaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics
The importance of oral microbiota has been recently highlighted in human health, such as in Parkinson disease, notably using shotgun metagenomics. One key aspect for efficient shotgun metagenomic analysis relies on optimal microbial sampling and DNA extraction, generally implementing commercial solutions developed to improve sample collection and preservation and provide high DNA quality and quantity for downstream analysis. Because metagenomic studies are today performed on a large number of samples, the next evolution to increase study throughput is with DNA extraction automation. In this study, we proposed a semi-automated DNA extraction protocol for human salivary samples collected with a commercial kit, and compared the outcomes with the DNA extraction recommended by the manufacturer. While similar DNA yields were observed between the protocols, our semi-automated DNA protocol significantly generated higher DNA fragment sizes. Moreover, we showed that the oral microbiome composition was equivalent between DNA extraction methods, even at the species level. This study demonstrates that our semi-automated protocol is suitable for shotgun metagenomic analysis, while allowing for a better sample treatment logistic with reduced technical variability and without compromising the structure of the oral microbiome.